Abstract
Objective
To determine the efficacy of minocycline and rifampin-impregnated catheters compared to non-impregnated catheters in critically ill patients.
Design
Prospective, randomized, double-blind, controlled, multicenter trial.
Setting
Intensive care units of seven acute-care teaching hospitals in Spain.
Patients
Intensive care unit patients requiring triple-lumen central venous catheter for more than 3 days.
Interventions
At catheter insertion, 228 patients were randomized to minocycline and rifampin-impregnated catheters and 237 to non-impregnated catheters. Skin, catheter tip, subcutaneous segment, hub cultures, peripheral blood and infusate cultures were performed at catheter withdrawal. The rate of colonization, catheter-related bloodstream infection (CRBSI) and catheter-related clinical infectious complications (purulence at the insertion site or CRBSI) were assessed.
Measurements and main results
In the intention-to-treat analysis (primary analysis), the episodes per 1000 catheter days of clinical infectious complications decreased from 8.6 to 5.7 (RR =0.67, 95% CI 0.31–1.44), CRBSI from 5.9 to 3.1 (RR =0.53, 95% CI 0.2–1.44) and tip colonization from 24 to 10.4 (RR =0.43, 95% CI 0.26–0.73). Antimicrobial-impregnated catheters were associated with a significant decrease of coagulase-negative staphylococci colonization (RR =0.24, 95% CI 0.13–0.45) and a significant increase of Candida spp. colonization (RR =5.84, 95% CI 1.31–26.1).
Conclusions
The use of antimicrobial-impregnated catheters was associated with a significantly lower rate of coagulase-negative staphylococci colonization and a significant increase in Candida spp. colonization, although a decrease in CRBSI, increase in 30-day survival or reduced length of stay was not observed.
Similar content being viewed by others
References
O’Grady NP, Alexander M, Patchen Dellinger E, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA (2002) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307
Edgeworth JD, Treacher DF, Eykyn SJ (1999) A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 27:1421–1428
Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S (1999) Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20:396–401
Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J (2000) Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162:1027–1030
Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess of stay, extra costs and attributable mortality. JAMA 272:1819–1820
Sitges-Serra A (1999) Strategies for prevention of catheter-related bloodstream infections. Support Care Cancer 7:391–395
Leon C, Alvarez-Lerma F, Ruiz-Santana S, Gonzalez V, de la Torre MV, Sierra R, Leon M, Rodrigo JJ (2003) Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study. Crit Care Med 31:1318–1324
Bach A, Bohrer H, Motsch J, Martin E, Geiss HK, Sonntag HG (1994) Prevention of bacterial colonization of intravenous catheter by antiseptic impregnation of polyurethane polymers. J Antimicrob Chemother 33:969–978
Greenfeld JI, Sampath L, Popilskis SJ, Brunnert SR, Stylianos S, Modak S (1995) Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters in swine. Crit Care Med 23:894–900
Maki DG, Cobb L, German JK, Shapiro JM, Ringer M, Helgerson RB (1988) An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 85:307–314
Kamal GD, Pfaller MA, Rempe LE, Jebson PJ (1991) Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 265:2364–2368
Logghe C, Van Ossel C, D’Hoore W, Ezzedine H, Wauters G, Haxh JJ (1997) Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 37:145–156
Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, Wall M, Harris R, Jones J, Buzaid A, Robertson C, Shanaq S, Curling P, Burke T, Ericsson C and the Texas Medical Center Catheter Study Group (1997) Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 127:267–274
Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD (1999) Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection. A meta-analysis. JAMA 281:261–267
Marin MG, Lee JC, Skurnick JH (2000) Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Crit Care Med 28:3332–3338
Raad II, Hanna HA (2002) Intravascular catheter-related infections. Arch Intern Med 162:871–878
Coopersmith CM, Rebmann TL, Zack JE, Ward MR, Corcoran RM, Schallom ME, Sona CS, Buchman TG, Boyle WA, Polish LB, Fraser VJ (2002). Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 30:59–64
Marik PE, Abraham G, Careau P, Varon J, Fromm RE Jr (1999) The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 27:1128–1131
Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G, for the Catheter Study Group (1999) A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 340:1–8
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
Maki DG, Weise CE, Sarafin HW (1977) A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296:1305–1309
Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL (1990) Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 28:76–82
Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP (1993) Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168:400–407
Sherertz RJ, Heard SO, Raad II (1997) Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication and flushing methodologies. J Clin Microbiol 35:641–646
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
Widmer AF, Frei R (2003) Diagnosis of central-venous catheter-related infection: comparison of the roll-plate and sonication technique in 1000 catheters (Abstract K-2036). 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois: American Society for Microbiology, p 398
Raad II, Darouiche RO, Hachem R, Abi-Said D, Safar H, Darnule T, Mansouri M, Morck D (1998) Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med 26:219–224
Bouza E, Alvarado N, Sánchez-Conde M, Rodríguez-Créixems M, Muñoz P, Alcalá L, Rodríguez C, Martín-Rabadán P (2003) A prospective comparative study of three methods for the laboratory diagnosis of central intravascular catheter tip colonization (CVCC) (Abstract K-2035). 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois: American Society for Microbiology, p 398
Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP (1995) Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 39:2397–2400
Gaonkar TA, Modak SM (2003) Comparison of microbial adherence to antiseptic and antibiotic central venous catheters using a novel agar subcutaneous infection model. J Antimicrob Chemother 52:389–396
Safdar N, Maki DG (2002) Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30:2632–2635
Rijnders BJ, Van Wijngaerden E, Peetermans WE (2002) Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 35:1053–1058
Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J, Ashline V, Kirkland K, Chou E, Hupert M, Veeder AV, Speas J, Kaye J, Sharma K, Martin A, Moroz VD, Gaynes RP (2003) Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 24:916–925
Ranucci M, Isgro G, Giomarelli PP, Pavesi M, Luzzani A, Cattabriga I, Carli M, Giomi P, Compostella A, Digito A, Mangani V, Silvestri V, Mondelli E and the Catheter Related Infection Trial (CRIT) Group (2003) Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 31:52–59
Veenstra DL, Saint S, Sullivan SD (1999) Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA 282:554–560
Acknowledgements>
We thank Marta Pulido, MD, for editing the manuscript and editorial assistance.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
This study was supported by a grant from Cook Europe.
Electronic Supplementary Material
Other members of the Cabaña Study Group
Other members of the Cabaña Study Group
Francisco Lucena, MD, Mario Márquez, MD, and José L. García, MD, Hospital Universitario de Valme, Sevilla; Juan J. Rodrigo, MD, and A. Bordes, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria; C. Ardanuy, MD, and C. Boqué, MD, Hospital Universitari Joan XXIII, Tarragona; I. Fernández, MD, and I. Viciana, MD, Hospital Clínico, Málaga; R. Ferrer, MD, and D. Mariscal, MD, Hospital Parc Taulí, Sabadell, Barcelona; M. Benazzuz, MD, and M.T. Torrella, MD, Hospital Universitari del Mar, Barcelona; A. Guerrero, MD, and P. Marín, MD, Hospital Puerta del Mar, Cádiz; E. Ramírez, MD, Hospital Clínico, Sevilla; and P. Pérez, MD, Cook España, Barcelona, Spain.
Rights and permissions
About this article
Cite this article
León, C., Ruiz-Santana, S., Rello, J. et al. Benefits of minocycline and rifampin-impregnated central venous catheters. Intensive Care Med 30, 1891–1899 (2004). https://doi.org/10.1007/s00134-004-2378-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-004-2378-2